BLood Groups as Biomarker to Optimize Odds of Response to Anti-PD-1 Drugs
Clinical trial NCT04473027 · TERMINATED
Trial details
- NCT number
- NCT04473027
- Sponsor
- University Hospital, Ghent
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2020-09-01
- Primary completion
- 2021-04-22
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.